TOMDF

Todos Med (CE) (TOMDF)

Todos Med Ltd (CE)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:TOMDF

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/07/17	21:29	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:TOMDF	Todos Med Ltd (CE)
2023/05/17	04:07	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:TOMDF	Todos Med Ltd (CE)
2023/04/01	05:04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2023/04/01	05:04	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2023/03/30	03:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TOMDF	Todos Med Ltd (CE)
2023/03/15	23:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/09/14	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/09/13	19:02	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/09/01	22:21	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/25	01:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/23	05:05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/23	05:04	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/16	05:33	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/13	05:05	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/11	05:41	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/06	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/08/03	22:48	InvestorsHub NewsWire	Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics	USOTC:TOMDF	Todos Med Ltd (CE)
2022/05/17	06:14	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/04/07	04:59	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/04/01	07:17	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/03/17	19:05	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/02/07	20:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:TOMDF	Todos Med Ltd (CE)
2022/01/27	22:30	InvestorsHub NewsWire	Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients	USOTC:TOMDF	Todos Med Ltd (CE)
2022/01/19	06:04	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:TOMDF	Todos Med Ltd (CE)
2021/12/03	00:39	InvestorsHub NewsWire	SA Breaking News - PURA expects to sign first contracts this month	USOTC:TOMDF	Todos Med Ltd (CE)
2021/11/30	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2021/11/16	20:09	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2021/10/23	04:06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2021/09/27	19:06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TOMDF	Todos Med Ltd (CE)
2021/09/24	22:59	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:TOMDF	Todos Med Ltd (CE)